Shopping Cart
- Remove All
- Your shopping cart is currently empty
K-TMZ is a DNA alkylating agent. It increases the concentration of O6-methylated deoxyguanosine in U87 glioblastoma multiforme (GBM) cells in a concentration-dependent manner. K-TMZ reduces cell viability of GBM cell lines lacking (IC50s = 18-44 μM) or expressing O6-methylguanine DNA methyltransferase (MGMT; IC50s = 115-240 μM). K-TMZ can cross the blood-brain barrier and increases survival in a Br23c mouse xenograft model of GBM when administered at a dose of 14.9 mg/kg.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $129 | Backorder | |
5 mg | $329 | Backorder | |
10 mg | $528 | Backorder |
Description | K-TMZ is a DNA alkylating agent. It increases the concentration of O6-methylated deoxyguanosine in U87 glioblastoma multiforme (GBM) cells in a concentration-dependent manner. K-TMZ reduces cell viability of GBM cell lines lacking (IC50s = 18-44 μM) or expressing O6-methylguanine DNA methyltransferase (MGMT; IC50s = 115-240 μM). K-TMZ can cross the blood-brain barrier and increases survival in a Br23c mouse xenograft model of GBM when administered at a dose of 14.9 mg/kg. |
Cas No. | 2269482-26-8 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | Ethanol: 10 mg/mL DMSO: 10 mg/mL Ethanol:PBS (pH 7.2) (1:2): 0.3 mg/mL DMF: 10 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.